Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hwang

Showing results (311-320 of 319) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 319 results.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaLung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, et al.
Future Oncology (London, England)|March 9, 2016
Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patientsJoseph M Unger, Dawn L Hershman, Kathryn B Arnold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2020
Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion UpdateJessica P Hwang, Jordan J Feld, Sarah P Hammond, et al.
Cancer|May 19, 2017
Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapyJessica P Hwang, Maria E Suarez-Almazor, Scott B Cantor, et al.
JAMA Oncology|January 18, 2019
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology PracticesScott D Ramsey, Joseph M Unger, Laurence H Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2018
Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort StudyJessica P Hwang, Anna S Lok, Michael J Fisch, et al.
Scientific Reports|September 17, 2024
Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment responseR F Valenzuela, E Duran-Sierra, M Canjirathinkal, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|February 15, 2023
Changes of antioxidant enzymes in the kidney after cardiac arrest in the rat modelJ H Lee, M S Islam, Y J Yoo, et al.
Genome Medicine|December 19, 2024
Structural variant allelic heterogeneity in MECP2 duplication syndrome provides insight into clinical severity and variability of disease expressionDavut Pehlivan, Jesse D Bengtsson, Sameer S Bajikar, et al.
Pageof 32

Showing results (311-320 of 319) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 319 results.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Global Epidemiology, Prevention, and Management of Hepatocellular CarcinomaLung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, et al.
Future Oncology (London, England)|March 9, 2016
Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patientsJoseph M Unger, Dawn L Hershman, Kathryn B Arnold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2020
Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion UpdateJessica P Hwang, Jordan J Feld, Sarah P Hammond, et al.
Cancer|May 19, 2017
Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapyJessica P Hwang, Maria E Suarez-Almazor, Scott B Cantor, et al.
JAMA Oncology|January 18, 2019
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology PracticesScott D Ramsey, Joseph M Unger, Laurence H Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2018
Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort StudyJessica P Hwang, Anna S Lok, Michael J Fisch, et al.
Scientific Reports|September 17, 2024
Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment responseR F Valenzuela, E Duran-Sierra, M Canjirathinkal, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|February 15, 2023
Changes of antioxidant enzymes in the kidney after cardiac arrest in the rat modelJ H Lee, M S Islam, Y J Yoo, et al.
Genome Medicine|December 19, 2024
Structural variant allelic heterogeneity in MECP2 duplication syndrome provides insight into clinical severity and variability of disease expressionDavut Pehlivan, Jesse D Bengtsson, Sameer S Bajikar, et al.
Pageof 32